{"nct_id":"NCT01768572","title":"To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2013-03","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}